Medicinova (MNOV) Asset Writedowns and Impairment (2011)

Medicinova's (MNOV) quarterly Asset Writedowns and Impairment came in at -$1038.0 in Q3 2011, down 100.21% on a QoQ basis from $493745.0 in Q2 2011.

Medicinova (MNOV) Asset Writedowns and Impairment (2011) Analysis & Trends

Medicinova (MNOV) has 1 years of Asset Writedowns and Impairment data on file, last reported at -$1038.0 in Q3 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,320.50 Bn	66,320.21 Bn	-
2	Nanobiotix	1,933.82 Bn	1,933.76 Bn	-
3	Akari Therapeutics	1,022.34 Bn	1,022.34 Bn	-
4	BeOne Medicines	472.93 Bn	468.14 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.22 Bn	114.98 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.96 Bn	61.21 Bn	3.31 Bn
7	Belite Bio	62.66 Bn	62.66 Bn	-
8	Argenx Se	56.07 Bn	50.89 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.60 Bn	34.59 Bn	959.66 Mn
10	Medicinova	64.27 Mn	64.27 Mn	4,754.00

Download Data